The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn or Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Acellular dermal matrices are used in tissue regeneration as skin substitutes. They are derived from human or animal dermis tissues and are used routinely in plastic and reconstructive surgeries.

Market key trends:-

One of the key trends in the U.S. acellular dermal matrices market is the growing demand for advanced wound care products. With rising incidences of diabetic foot ulcers and pressure ulcers, there is increasing demand for acellular dermal matrices for wound closure and healing. These dermal matrices help regenerate tissue and promotes wound healing. Additionally, technologically advanced acellular matrices that mimic natural extracellular matrix are gaining traction. Products infused with growth factors or cells expedite wound healing.

Market key trends:-

The U.S. acellular dermal matrices market has been witnessing high growth over the past few years. One of the key trends driving the growth of this market is the increasing use of acellular dermal matrices for hernia repair surgeries. Acellular dermal matrices are widely used in hernia repair procedures due to their ability to reinforce and strengthen weak tissue areas. Moreover, with rising geriatric population and increasing incidence of hernias, the demand for hernia repair surgeries using acellular dermal matrices is expected to rise in the country.

SWOT Analysis

• Strength: Acellular dermal matrices offer effective tissue reinforcement and reduce postoperative hernia recurrence rates. They help integrate well with the native tissue.
• Weakness: High costs associated with acellular dermal matrices can limit their adoption.
• Opportunity: Growing geriatric population prone to hernias creates growth opportunities. Increasing awareness about benefits of acellular dermal matrices also presents opportunities.
• Threats: Stringent regulatory approvals and recalls of dermal matrix products pose threats. Reimbursement issues also restrict market growth.

Key Takeaways:-

The U.S. Acellular Dermal Matrices Market Size was valued at US$ 2783.32 Mn in 2023 and is expanding at a CAGR of 3.8% during the forecast period.

The rising incidence of hernias coupled with the growing geriatric population in the U.S. is a major factor driving the demand for acellular dermal matrices in the country. According to the National Center for Biotechnology Information (NCBI), groin hernias account for 75% of all hernias in the U.S., with over 1 million repairs done every year.

Regionally, the South region dominated the U.S. acellular dermal matrices market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to the presence of major market players andavailability of advanced healthcare facilities in states such as Florida, Texas and North Carolina.

Key players operating in the U.S. Acellular Dermal Matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.

Read More - https://www.insightprobing.com/u-s-acellular-dermal-matrices-market-forecasts-and-outlook-analysis/